Safety of human papillomavirus (HPV) vaccines: A review of the international experience so far
Theodoros Agorastos, Konstantinos Chatzigeorgiou, Julia ML Brotherton, Suzanne M Garland
Vaccine | ELSEVIER SCI LTD | Published : 2009
Professor Suzanne Marie Garland has received advisory board fees and grant support from Commonwealth Serum Laboratories and GlaxoSmithKline, and lecture fees from Merck and GSK. Suzanne has received funding through her institution to conduct HPV vaccine studies for MSD and GSK.